diabetes

Showing 2 posts of 392 posts found.

New diabetes drug Byetta set for European approval

September 22, 2006
Sales and Marketing Byetta, diabetes

Lilly and Amylin's new diabetes treatment Byetta is set for European approval following recommendation from medicines regulator the EMEA.Byetta (exenatide) …

Pfizer to go it alone with Exubera

January 16, 2006
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

 Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …

The Gateway to Local Adoption Series

Latest content